{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T20:16:28Z","timestamp":1715890588013},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s20655","type":"journal-article","created":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T11:38:01Z","timestamp":1340624281000},"page":"465","source":"Crossref","is-referenced-by-count":1,"title":["Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain"],"prefix":"10.2147","author":[{"given":"Eric","family":"Prommer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandy","family":"Ficek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,6]]},"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=13081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:18:55Z","timestamp":1477865935000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/fentanyl-transmucosal-tablets-current-status-in-the-management-of-canc-peer-reviewed-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ppa.s20655","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}